WHITNEY CROW: Open Payments
NPI 1831446806 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,620 in 126 payments from 17 companies in 2025. Trend: 2023 $965 · 2024 $1,778 · 2025 $2,620
Food & beverage: $2,570Education: $50
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $346 |
| Mallinckrodt Hospital Products Inc. | 13 | $310 |
| UCB, Inc. | 13 | $253 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $250 |
| Galderma Laboratories, L.P. | 7 | $237 |
| LEO Pharma Inc. | 10 | $219 |
| Janssen Biotech, Inc. | 11 | $203 |
| GENZYME CORPORATION | 8 | $187 |
| Regeneron Healthcare Solutions, Inc. | 11 | $171 |
| Arcutis Biotherapeutics, Inc. | 2 | $155 |
Products named: DUPIXENT, ACTHAR, Bimzelx, NEMLUVIO, TREMFYA, ILUMYA, RINVOQ, SKYRIZI.
Industry payments across MS — which companies pay providers there.
